Canadian generic drug manufacturer Apotex Inc. is considering an initial public offering in the coming year, with RBC Capital Markets, Jefferies Financial Group, and TD Securities as advisers.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing